This article highlights recent research on breast cancer, lung cancer, melanoma, head and neck cancer, and hematologic malignancies.

Patients with advanced desmoplastic melanoma have high response to single-agent anti-programmed death protein 1 (PD-1) ...

Pembrolizumab showed an 89% objective response rate in unresectable desmoplastic melanoma, with a 37% complete response rate.

A research team co-led by UCLA investigators has found that pembrolizumab, an immunotherapy drug that helps the immune system ...

A research team co-led by UCLA investigators has found that pembrolizumab, an immunotherapy drug that helps the immune system attack cancer cells, can ...

Inside Your Health: Melanoma Summer is almost over, but protecting your skin from the sun should last all year long, especially in Minnesota.

The Richard David Kann (RDK) Melanoma Foundation held its silver anniversary fundraiser, featuring a Carolina Herrera fashion show. Wes Gordon, Carolina Herrera's creative director, presented the ...

Melanoma testing could one day be done at home with a skin patch and test strip with two lines, similar to COVID-19 home tests, according to University of Michigan researchers.

(RTTNews) - Castle Biosciences, Inc. (CSTL), Wednesday said that its DecisionDx-Melanoma test has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA).

A Miss Universe who thought it was just a mole, a college cheerleader who loved to tan: 4 women on having melanoma 'I could have detected it earlier — I just wasn’t paying attention.' ...

A new treatment for advanced melanoma is showing promising results for people whose tumors have stopped responding to existing therapies.

A real-world study showed a 49% response rate with Amtagvi in patients with advanced melanoma, supporting earlier use after immunotherapy.